SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Colorado MEDtech, CMED

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark Johnson who wrote (4)5/23/1997 12:07:00 AM
From: henry jakala   of 288
 
looks like CMED has a fan, unfortunately it's Meyerson - get ready
for some volatility IMHO. i suspect they probably make a market in CMED too.

so what's the latest ? - earnings were somewhat flat but with the acquisition and all the future seems bright

JERSEY CITY, N.J., May 22 /PRNewswire/ -- M.H. Meyerson & Co., Inc. (Nasdaq:
MHMY) announced a Research Report available on Colorado MEDtech, Inc.,
(Nasdaq: CMED) rated BUY (2): prepared by Andrew H. Scott of M.H. Meyerson &
Co., Inc., 525 Washington Blvd., Jersey City, New Jersey 07310.
"The latest rage in the outsourcing industry has been found in the medical
device sector. Colorado MEDtech appears as an attractive investment
opportunity. We believe the Company is capable of growing 35% top and bottom-
line over the next several years."
/CONTACT: Andrew H. Scott, Senior Research Analyst of M.H. Meyerson,
201-459-9500, 800-888-8118 or web site: www.mhmeyerson.com/
09:02 EDT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext